enquiry@dsij.in |+91 9240904920
SENSEX-242.65
72,529.07-0.33%

Lupin Ltd.

(Industry - Pharmaceuticals & Drugs)

₹2,060

-1.85 (-0.09%)
BSE: 500257 | NSE: LUPIN
Website: http://www.lupin.com

Today High/Low

L
H
₹2,060₹2,097

52 Week High/Low

L
H
₹1,905.7₹2,514.4

About Company

Lupin Limited develops, manufactures and markets pharmaceutical products globally. Its main business includes generic medicines, complex generics, specialty products, biosimilars, respiratory therapies, injectables and peptides, supported by API and contract development and manufacturing capabilities. The company reaches patients through wholesalers, distributors, pharmacies, hospitals, healthcare systems and public-health agencies, while also serving pharmaceutical partners. India is a core market and global capability base, alongside operations in the United States, Europe, Australia, Canada and emerging markets.

Market Cap.
₹94,201.74 Cr.
P/E Ratio
16.97
P/B Ratio
2.87
Current Price
₹2,060
Open
₹2,071.85
High
₹2,097
Prev Close
₹2,061.85
Quantity Traded
15,360
52 Week High
₹2,514.4
52 Week Low
₹1,905.7
Dividend Yield
0.87%
EBITDA Margin
32.90%
ROE
24.80%
Book Value
₹716.98
Face Value
₹2
MindshareMutual FundQuarterly ResultsInterviewsIPO AnalysisMultibaggerPenny StocksDividendBonus & Stock SplitSMEPersonal FinanceSwing Trading

If you want to stay updated with the Share Market News Today, keep a close watch on the Indian Stock Market Today with real time movements like Sensex Today Live and overall trends. Investors tracking IPO Allotment Status, IPO News Today, or the Latest IPO India can also follow daily updates along with BSE Share Price Live data. Whether you are learning How To Invest in Stock Market in India, preparing for a Market Crash Today, or searching for the Best Stocks to Buy in India, insights on Top Gainers Today India, Top Losers Today India, Trending Stocks India and Long Term Stocks India help in making informed investment decisions.

Stay informed, stay disciplined, and make smarter investment choices with timely and reliable market insights.